Skip to Content

Allscripts Healthcare Solutions Inc MDRX

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Allscripts Reports Improved but Slowing Efficiency Gains; Maintaining $11.40 Fair Value Estimate

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

No-moat Allscripts posted second-quarter results that were largely in line with our expectations. The firm was successful in improving operational efficiency, while sales remained relatively stable. Management announced a new partnership with PRA Health Sciences as well as an expansion to its cloud partnership with Microsoft. However, we remain pessimistic about the company’s ability to grow market share long term and maintain our fair value estimate of $11.40 per share.

Read Full Analysis

Company Profile

Business Description

Allscripts Healthcare Solutions provides information technology and offerings to acute and ambulatory providers as well as hospital services. The company supports electric medical records, private cloud hosting, and other clinical services that support patient engagement and better outcomes. Additionally, the company offers administrative tools and services to improve operations, such as practice management, revenue cycle management, and clinical care coordination. Allscripts was founded in 1986 and is headquartered in Chicago.

222 Merchandise Mart Plaza, Suite 2024
Chicago, IL, 60654
T +1 800 334-8534
Sector Healthcare
Industry Health Information Services
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2021
Stock Type Slow Growth
Employees 8,400